243 related articles for article (PubMed ID: 18691012)
1. Molecular targeting of acid ceramidase: implications to cancer therapy.
Zeidan YH; Jenkins RW; Korman JB; Liu X; Obeid LM; Norris JS; Hannun YA
Curr Drug Targets; 2008 Aug; 9(8):653-61. PubMed ID: 18691012
[TBL] [Abstract][Full Text] [Related]
2. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
Huwiler A; Pfeilschifter J
Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
[TBL] [Abstract][Full Text] [Related]
3. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
4. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
Huwiler A; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.
Morad SA; Cabot MC
Biochim Biophys Acta; 2015 Sep; 1851(9):1134-45. PubMed ID: 25964209
[TBL] [Abstract][Full Text] [Related]
6. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
[TBL] [Abstract][Full Text] [Related]
7. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.
Tani M; Ito M; Igarashi Y
Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225
[TBL] [Abstract][Full Text] [Related]
8. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
[TBL] [Abstract][Full Text] [Related]
9. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
10. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
[TBL] [Abstract][Full Text] [Related]
11. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.
Mao C; Obeid LM
Biochim Biophys Acta; 2008 Sep; 1781(9):424-34. PubMed ID: 18619555
[TBL] [Abstract][Full Text] [Related]
12. Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come?
Radin NS
Eur J Biochem; 2001 Jan; 268(2):193-204. PubMed ID: 11168352
[TBL] [Abstract][Full Text] [Related]
13. Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.
Blaho VA
Adv Exp Med Biol; 2020; 1274():101-135. PubMed ID: 32894509
[TBL] [Abstract][Full Text] [Related]
14. Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins.
Linke T; Wilkening G; Sadeghlar F; Mozcall H; Bernardo K; Schuchman E; Sandhoff K
J Biol Chem; 2001 Feb; 276(8):5760-8. PubMed ID: 11104761
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipid metabolism and leukemia: a potential for novel therapeutic approaches.
Burns TA; Luberto C
Anticancer Agents Med Chem; 2011 Nov; 11(9):863-81. PubMed ID: 21707485
[TBL] [Abstract][Full Text] [Related]
16. Neutral ceramidase: Advances in mechanisms, cell regulation, and roles in cancer.
Coant N; Hannun YA
Adv Biol Regul; 2019 Jan; 71():141-146. PubMed ID: 30389354
[TBL] [Abstract][Full Text] [Related]
17. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
19. Regulation of alkaline ceramidase activity by the c-Src-mediated pathway.
Sasaki H; Toyomura K; Matsuzaki W; Okamoto A; Yamaguchi N; Nakamura H; Murayama T
Arch Biochem Biophys; 2014 May; 550-551():12-9. PubMed ID: 24708996
[TBL] [Abstract][Full Text] [Related]
20. Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids.
Kono M; Dreier JL; Ellis JM; Allende ML; Kalkofen DN; Sanders KM; Bielawski J; Bielawska A; Hannun YA; Proia RL
J Biol Chem; 2006 Mar; 281(11):7324-31. PubMed ID: 16380386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
